MASATAKA SUZUKI to Antibodies, Monoclonal
This is a "connection" page, showing publications MASATAKA SUZUKI has written about Antibodies, Monoclonal.
Connection Strength
0.415
-
Armed Oncolytic Adenovirus-Expressing PD-L1 Mini-Body Enhances Antitumor Effects of Chimeric Antigen Receptor T Cells in Solid Tumors. Cancer Res. 2017 04 15; 77(8):2040-2051.
Score: 0.238
-
Targeted gene delivery using humanized single-chain antibody with negatively charged oligopeptide tail. Cancer Sci. 2004 May; 95(5):424-9.
Score: 0.098
-
Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity. Mol Ther. 2021 05 05; 29(5):1808-1820.
Score: 0.078